Scientific and Regulatory Considerations for Long Acting Injectable Suspensions 21Jul2023
Автор: IQConsortium
Загружено: 2025-11-24
Просмотров: 9
Webinar presented on July 21, 2023
Long-acting injectable (LAI) suspensions has been emerging as a new formulation modality of patient centricity. There has been an increasing number of LAI suspension products approved by the Agency in recent years. However, the research and development of LAI suspensions are facing tremendous challenges due to the lack of understanding of the formulation, in vitro release and in vitro-in vivo correlations or relationship (IVIVC/IVIVR). In addition, there has been no guidance for industry regarding this area.
IQ Consortium
Drug Product Leadership Group
Long Acting Injectables Working Group
Learn more at iqconsortium.org
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: